Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
NeuroSense Therapeutics (NRSN)
- 0.7000
- -0.0300-4.11%
Close Apr 10 15:59 ET
- 0.6859
- -0.0141-2.01%
Post 17:33 ET
24.74MMarket Cap-1.59P/E (TTM)
0.7320High0.6839Low94.83KVolume0.7100Open0.7300Prev Close66.42KTurnover0.36%Turnover RatioLossP/E (Static)35.35MShares2.600052wk High-15.91P/B18.35MFloat Cap0.630052wk Low--Dividend TTM26.21MShs Float8.1800Historical High--Div Yield TTM6.59%Range %0.4000Historical Low0.7000Avg Price1Lot Size
NeuroSense Therapeutics (NRSN) Key Financial Indicators
NRSN Earnings per Share (EPS)
According to the latest financial report of NeuroSense Therapeutics, the latest earnings per share (TTM) for the company is -0.06. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
NRSN Free Cash Flow (FCF)
Interested in knowing about NeuroSense Therapeutics's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
NRSN Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of NeuroSense Therapeutics shows that the company's current ratio is 0.31, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
NRSN Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of NeuroSense Therapeutics, the quick ratio is 0.08, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
NRSN Return on Equity (ROE)
Want to learn more about the financial health of NeuroSense Therapeutics? The latest ROE figure is -542.56%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
NRSN Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of NeuroSense Therapeutics, the total asset return on investment (ROA) is -64.80%.
Currency: USD
Quarterly
Loading...
NRSN Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check NeuroSense Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
NRSN Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of NeuroSense Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm